Svas Biosana Past Earnings Performance
Past criteria checks 2/6
Svas Biosana has been growing earnings at an average annual rate of 21.6%, while the Medical Equipment industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 16.7% per year. Svas Biosana's return on equity is 8.7%, and it has net margins of 4.2%.
Key information
21.6%
Earnings growth rate
-2.1%
EPS growth rate
| Medical Equipment Industry Growth | 8.3% |
| Revenue growth rate | 16.7% |
| Return on equity | 8.7% |
| Net Margin | 4.2% |
| Last Earnings Update | 31 Dec 2023 |
Revenue & Expenses Breakdown
How Svas Biosana makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 122 | 5 | 19 | 0 |
| 30 Sep 23 | 117 | 5 | 19 | 0 |
| 30 Jun 23 | 112 | 4 | 15 | 0 |
| 31 Mar 23 | 106 | 4 | 14 | 0 |
| 31 Dec 22 | 100 | 4 | 18 | 0 |
| 30 Sep 22 | 94 | 3 | 15 | 0 |
| 30 Jun 22 | 88 | 3 | 12 | 0 |
| 31 Mar 22 | 85 | 3 | 11 | 0 |
| 31 Dec 21 | 82 | 3 | 11 | 0 |
| 30 Sep 21 | 80 | 3 | 15 | 0 |
| 30 Jun 21 | 79 | 3 | 19 | 0 |
| 31 Mar 21 | 78 | 3 | 15 | 0 |
| 31 Dec 20 | 77 | 3 | 12 | 0 |
Quality Earnings: SVS has a large one-off gain of €1.3M impacting its last 12 months of financial results to 31st December, 2023.
Growing Profit Margin: SVS's current net profit margins (4.2%) are higher than last year (3.6%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if SVS's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare SVS's past year earnings growth to its 5-year average.
Earnings vs Industry: SVS earnings growth over the past year (43.5%) exceeded the Medical Equipment industry -16.6%.
Return on Equity
High ROE: SVS's Return on Equity (8.7%) is considered low.